Loading insider details...
Beta
Latest Form 4 (Jun 5, 2026): Grant/Award of 42,000 PMVP shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 5, 2026 | PMV Pharmaceuticals, Inc. (PMVP) | Grant/Award | 42,000 | n/a |
| Jun 13, 2025 | Atara Biotherapeutics, Inc. (ATRA) | Grant/Award | 7,828 | n/a |
| Jun 9, 2025 | PMV Pharmaceuticals, Inc. (PMVP) | Grant/Award | 33,500 | n/a |
| Jun 10, 2024 | PMV Pharmaceuticals, Inc. (PMVP) | Grant/Award | 67,500 | n/a |
| Apr 2, 2024 | Atara Biotherapeutics, Inc. (ATRA) | Grant/Award | 150,000 | n/a |
| Jan 23, 2024 | Mirati Therapeutics, Inc. (MRTX) | Disposition to Issuer | 7,555 | n/a |
| Nov 15, 2023 | Atara Biotherapeutics, Inc. (ATRA) | Purchase | 179,020 | $40.0K |
| Jun 12, 2023 | PMV Pharmaceuticals, Inc. (PMVP) | Grant/Award | 21,500 | n/a |
| Jun 2, 2023 | Atara Biotherapeutics, Inc. (ATRA) | Grant/Award | 57,000 | n/a |
| Nov 8, 2022 | PMV Pharmaceuticals, Inc. (PMVP) | Grant/Award | 39,000 | n/a |